ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Process Chemistry

Thermo Fisher to buy bioprocessing business from Becton Dickinson

by Marc S. Reisch
September 14, 2018 | APPEARED IN VOLUME 96, ISSUE 37

 

Thermo Fisher Scientific has signed a definitive agreement to acquire the bioprocessing business of medical technology firm Becton, Dickinson & Co. The acquisition, for an undisclosed amount, will give Thermo Fisher a business that provides peptones to biopharmaceutical customers to enhance cell culture media formulations. Thermo Fisher says the business, which has about $100 million in annual sales, will complement its existing bioproduction offerings. The deal is expected to close in early 2019.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment